参考文献/References:
[1] Rodríguez-Hernández H,Simental-Mendía LE,Rodríguez-Ramírez G,et al．Obesity and inflammation：epidemiology,risk factors, and markers of inflammation[J]．Int J Endocrinol,2013,2013：678159.
[2] Yamawaki H,Kuramoto J,Kameshima S,et al．Omentin,a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells[J]．Biochem Biophys Res Commun,2011,
408（2）：339-343.
[3] Yang RZ,Lee MJ,Hu H,et al．Identification of omentin as a novel depot-specific adipokine in human adipose tissue：possible role in modulating insulin action[J]．Am J Physiol Endocrinol Metab,2006,290（6）：E1253-E1261.
[4] Mahde A,Shaker M,Al-Mashhadani Z．Study of omentin1 and other adipokines and hormones in PCOS patients[J]．Oman Med J, 2009,24（2）：108-118.
[5] Barker G,Lim R,Georgiou HM,et al．Omentin-1 is decreased in maternal plasma,placenta and adipose tissue of women with pre-existing obesity[J]．PLoS One,2012,7（8）：e42943.
[6] Zhong X,Li X,Liu F,et al．Omentin inhibits TNF-alpha-induced expression of adhesion molecules in endothelial cells via ERK/NF-kappaB pathway[J]．Biochem Biophys Res Commun,2012,425（2）：401-406.
[7] Kazama K,Usui T,Okada M,et al．Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells[J]．Eur J Pharmacol,2012,686（1-3）：116-123.
[8] Yamawaki H,Tsubaki N,Mukohda M,et al．Omentin,a novel adipokine,induces vasodilation in rat isolated blood vessels[J]．Biochem Biophys Res Commun,2010,393（4）：668-672.
[9] Illán-Gómez F,Gonzálvez-Ortega M,Orea-Soler I,et al．Obesity and inflammation：change in adiponectin,C-reactive protein,tumour necrosis factor-alpha and interleukin-6 after bariatric surgery[J]．Obes Surg,2012,22（6）：950-955.
[10] de Souza Batista CM,Yang RZ,Lee MJ,et al．Omentin plasma levels and gene expression are decreased in obesity[J]．Diabetes,2007,56（6）：1655-1661.
[11] Moreno-Navarrete JM,Catalán V,Ortega F,et al．Circulating omentin concentration increases after weight loss[J]．Nutr Metab（Lond）, 2010,7：27.
[12] Saremi A,Asghari M,Ghorbani A．Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men[J]．J Sports Sci,2010,28（9）：993-998.
[13] Ohashi K,Parker JL,Ouchi N,et al．Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype[J]．J Biol Chem,2010,285（9）：6153-6160.
[14] Dali-Youcef N,Mecili M,Ricci R,et al．Metabolic inflammation： connecting obesity and insulin resistance[J]．Ann Med,2013,45（3）：242-253.
[15] Pan HY,Guo L,Li Q．Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes[J]．Diabetes Res Clin Pract,2010,88（1）：29-33.
[16] Yan P,Liu D,Long M,et al．Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus[J]．Exp Clin Endocrinol Diabetes,2011,119（4）：257-263.
[17] Choi JH,Rhee EJ,Kim KH,et al．Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome[J]．Eur J Endocrinol,2011,165（5）：789-796.
[18] Akbarzadeh S,Nabipour I,Assadi M,et al．The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels[J]．Cytokine,2012,58（2）：295-299.
[19] Shibata R,Takahashi R,Kataoka Y,et al．Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men[J]．Hypertens Res,2011,34（12）：1309-1312.
[20] Shibata R,Ouchi N,Kikuchi R,et al．Circulating omentin is associated with coronary artery disease in men[J]．Atheroscl-
erosis,2011,219（2）：811-814.
[21] Yoo HJ,Hwang SY,Hong HC,et al．Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus[J]． Endocrine,2013,44（3）：680-687.
[22] Tom FQ,Gauvreau D,Lapointe M,et al．Differential chemoat-
tractant response in adipocytes and macrophages to the action of acylation stimulating protein[J]．Eur J Cell Biol,2013,92（2）：61-69.
[23] Cui W,Paglialunga S,Kalant D,et al．Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo[J]．Am J Physiol Endocrinol Metab,2007,293（6）：E1482-E1491.
[24] Lu H,Gauvreau D,Tom FQ,et al．Inflammatory markers and adipokines alter adipocyte-derived ASP production through direct and indirect immune interaction[J]．Exp Clin Endocrinol Diabetes,2013, 121（4）：194-200.
[25] García-Heredia A, Kensicki E,Mohney RP,et al．Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet：a metabolomic approach[J]．
J Proteome Res,2013,[Epub ahead of print].
[26] Guo XD,Zhang DY,Gao XJ,et al．Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation[J]．Mol Nutr Food Res,2013,57（6）：1037-1045.
[27] Yilmaz Y,Yonal O,Kurt R,et al．Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease[J]．Scand J Gastroenterol,2011,46（1）：91-97.
[28] Tan BK,Adya R,Farhatullah S,et al．Omentin-1,a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome：ex vivo and in vivo regulation of omentin-1 by insulin and glucose[J]．Diabetes,2008,57（4）：801-808.
[29] Yan P,Li L,Yang M,et al．Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus[J]．Diabetes Res Clin Pract,2011,92（3）：368-374.
相似文献/References:
[1]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[2]刘琦,周赛君,孟振兴,等.P2X7受体与糖尿病视网膜病变[J].国际内分泌代谢杂志,2015,(02):127.[doi:10.3760/cma.j.issn.1673-4157.2015.02.015]
Liu Qi,Zhou Saijun,Meng Zhenxing,et al.P2X7 receptor and diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2015,(01):127.[doi:10.3760/cma.j.issn.1673-4157.2015.02.015]
[3]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[4]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(01):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[5]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(01):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[6]冯红,徐勇,苟芳,等.炎症小体与糖尿病并发症[J].国际内分泌代谢杂志,2014,(01):46.[doi:10.3760/cma.j.issn.1673-4157.2014.01.013]
Feng Hong,Xu Yong,Gou Fang,et al.Inflammasome and diabetic complications[J].International Journal of Endocrinology and Metabolism,2014,(01):46.[doi:10.3760/cma.j.issn.1673-4157.2014.01.013]
[7]王兴纯,曲伸.GLP-1及其受体激动剂与炎性反应及氧化应激[J].国际内分泌代谢杂志,2014,(04):263.[doi:10.3760/cma.j.issn.1673-4157.2014.04.014]
Wang Xingchun,Qu Shen..Association of GLP-1 and its receptor agonist with inflammation and oxidative stress[J].International Journal of Endocrinology and Metabolism,2014,(01):263.[doi:10.3760/cma.j.issn.1673-4157.2014.04.014]
[8]郑仁东 刘超.炎性反应与甲状腺肿瘤[J].国际内分泌代谢杂志,2015,(06):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
Zheng Rendong,Liu Chao.Inflammation and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2015,(01):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
[9]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
[10]郑辉,葛焕琦.网膜素对心血管系统的影响[J].国际内分泌代谢杂志,2016,36(04):261.[doi:10.3760/cma.j.issn.1673-4157.2016.04.12]
Zheng Hui,Ge Huanqi.Effects of omentin on cardiovascular system[J].International Journal of Endocrinology and Metabolism,2016,36(01):261.[doi:10.3760/cma.j.issn.1673-4157.2016.04.12]